MLMCX
Price
$21.64
Change
+$0.15 (+0.70%)
Updated
Aug 7 closing price
Net Assets
45.28M
RPEBX
Price
$68.50
Change
+$0.16 (+0.23%)
Updated
Aug 7 closing price
Net Assets
156.62B
Interact to see
Advertisement

MLMCX vs RPEBX

Header iconMLMCX vs RPEBX Comparison
Open Charts MLMCX vs RPEBXBanner chart's image
Morgan Stanley Instl Global Core C
Price$21.64
Change+$0.15 (+0.70%)
VolumeN/A
Net Assets45.28M
American Funds New Perspective R2E
Price$68.50
Change+$0.16 (+0.23%)
VolumeN/A
Net Assets156.62B
MLMCX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MLMCX vs. RPEBX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLMCX is a Buy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 157B vs. MLMCX (45.3M). RPEBX pays higher dividends than MLMCX: RPEBX (0.12) vs MLMCX (0.00). MLMCX was incepted earlier than RPEBX: MLMCX (9 years) vs RPEBX (11 years). MLMCX (2.80) is less costly to investors than RPEBX (1.21). MLMCX is a more actively managed with annual turnover of: 39.00 vs. RPEBX (24.00). RPEBX has a lower initial minimum investment than MLMCX: RPEBX (250) vs MLMCX (1000). MLMCX annual gain was more profitable for investors over the last year : 22.45 vs. RPEBX (18.92). MLMCX return over 5 years is better than : 59.54 vs. RPEBX (34.73).
MLMCXRPEBXMLMCX / RPEBX
Total Expense Ratio2.101.21174%
Annual Report Gross Expense Ratio2.801.21231%
Fund Existence9 years11 years-
Gain YTD8.92013.46766%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets45.3M157B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year22.4518.92119%
Returns for 3 years48.6234.78140%
Returns for 5 years59.5434.73171%
Returns for 10 yearsN/A75.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS9.390.64
+7.31%
Viatris
VYNE0.380.01
+3.32%
VYNE Therapeutics
PLOW30.770.20
+0.65%
Douglas Dynamics
HLVX2.060.01
+0.49%
HilleVax
CVBF19.03-0.01
-0.05%
CVB Financial Corp